Description:
Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated research activities.
Kalorama Information’s report, Outsourcing in Drug Discovery, 9th Edition, delves into current trends shaping the market and offers a detailed analysis of the global landscape, both present and future.
Key Features of the Report:
This extensive market analysis provides crucial data and strategic planning resources for stakeholders in the drug discovery outsourcing market. Key highlights include:
- Global Market Projections: Analysis from 2019 to 2024, including market segments such as Chemistry, Biology, HTS, Lead Optimization, and the overall market.
- Segment Market Share: Insights into the market share of different segments in 2019 and projections for 2024.
- Revenue Analysis: Detailed revenue breakdowns for Chemistry, Biology, HTS, and Lead Optimization services, along with annual growth and market share.
Market Insights:
- Trends Driving Demand: Key trends increasing the need for contract services in drug discovery, including technological advancements, patent expirations, time-to-market pressures, and the shift from fixed to variable costs.
- Globalization of Contract Research: Expansion of international CROs into Asia, particularly China and India, and the rise of outsourcing in Eastern Europe.
- Outsourcing Models and Challenges: Examination of CRO roles, effective communication strategies for partnerships, and IP protection challenges.
COVID-19 Impact Analysis:
No market report today would be complete without considering the impact of the COVID-19 pandemic. This report examines:
- Global Macro Trends and Coronavirus: Broad economic implications of the pandemic.
- Supply Chain Impact: How COVID-19 has disrupted supply chains.
- Cultural Implications: Changes in workplace and cultural norms due to the pandemic.
- R&D Spending: Adjustments in research and development spending in response to COVID-19.
- Opportunities and Challenges: New opportunities created by the pandemic and related challenges, especially in outsourcing to China, India, and Eastern Europe.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global Drug Discovery Outsourcing Market, 2014-2024 ($ billion)
| Year | Global Market | Percent Increase |
| 2014 | $XX Million | XX% |
| 2015 | $XX Million | XX% |
| 2016 | $XX Million | XX% |
| 2017 | $XX Million | XX% |
| 2018 | $XX Million | XX% |
| 2019 | $XX Million | XX% |
| 2020 | $XX Million | XX% |
| 2021 | $XX Million | XX% |
| 2022 | $XX Million | XX% |
| 2023 | $XX Million | XX% |
| 2024 | $XX Million | XX% |
| Compound Annual Growth Rate | ||
| 2014 – 2019 | XX% | |
| 2019 – 2024 | XX% | |
| 2014 – 2024 | XX% | |
Source: Kalorama Information
